US2020139151A1PendingUtilityA1

System and method for optogenetic therapy

74
Assignee: CIRCUIT THERAPEUTICS INCPriority: Nov 21, 2012Filed: Jan 15, 2020Published: May 7, 2020
Est. expiryNov 21, 2032(~6.4 yrs left)· nominal 20-yr term from priority
A61B 2017/3413A61N 1/0551A61K 38/168A61P 9/12A61N 5/0601A61N 2005/0653A61N 2005/0651A61N 2005/0665A61B 17/3403A61K 38/164A61B 17/00234A61N 5/0622A61M 37/0015A61N 1/3605A61M 25/0105A61N 5/062A61K 38/177A61N 2005/0631A61M 2037/0061A61N 2005/0626A61M 2205/50A61M 25/0147A61N 2005/0627A61N 2005/063A61M 5/20A61M 5/142A61N 2005/0612A61N 1/36053A61K 48/00A61N 2005/0643A61M 2205/3576A61K 41/00A61K 41/0057A61K 38/16A61K 48/0075A61M 2037/0023A61N 2005/067A61N 5/067
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.

Claims

exact text as granted — not AI-modified
1 . A method for injecting a targeted tissue structure, comprising:
 a. selecting the targeted tissue structure to be injected;   b. providing an elongate flexible injection member biased to assume an arcuate geometric configuration when unloaded, the injection member comprising an array of injection needles and being configured to assume a substantially straight geometric configuration based upon an input from an operator manipulating a remote actuator that is operatively coupled to the elongate flexible injection member;   c. causing the elongate flexible injection member to assume the substantially straight configuration based upon an input from the operator;   d. navigating the elongate flexible injection member into a position relative to the targeted tissue structure such that upon release of the input, the flexible injection member will be biased to return to the arcuate geometric configuration, and in reconfiguring toward the arcuate configuration, portions of the elongate flexible member will advance a plurality of the injection needles into the targeted tissue structure;   e. releasing the input to advance the plurality of the injection needles into the targeted tissue structure; and   f. injecting the targeted tissue structure using the plurality of needles advanced into the targeted tissue structure.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.